Purines and the Health of Retinal Ganglion Cells
嘌呤与视网膜神经节细胞的健康
基本信息
- 批准号:8651585
- 负责人:
- 金额:$ 29.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-06-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgeAnimalsAstrocytesAxonBlindnessBrainCell DeathCellsCessation of lifeChronicChronic DiseaseCustomCytokine ActivationCytoskeletonDataDiseaseEyeGene ActivationGenesGlaucomaGoalsHealthIn VitroInflammationInflammatoryInflammatory ResponseInjuryInterleukin-1Interleukin-6InterventionKnockout MiceLeadLinkMechanicsMembraneMessenger RNAModelingMolecularMusMutationNeurodegenerative DisordersNeuronsOptic DiskOptic NervePathogenesisPathologyPathway interactionsPharmaceutical PreparationsPhysiologic Intraocular PressurePredispositionProcessProteinsPurinesRelative (related person)ResearchRetinaRetinal Ganglion CellsRiskRisk FactorsRodentRoleRouteSeriesSignal PathwaySignal TransductionStressStretchingTestingTimeUp-Regulationbasecell injurychannel blockerscytokinedesignextracellularin vitro Modelin vivoin vivo Modelinjuredinsightneuronal transportnovelnovel strategiesnovel therapeutic interventionnovel therapeuticspatch clamppressurepreventpublic health relevancepurinereceptorresponsetool
项目摘要
Project Summary
Glaucoma is a major cause of blindness worldwide and is characterized by a
series of pathological changes to optic nerve head astrocytes and retinal
ganglion cells that eventually lead to vision loss. While the biggest risk factor for
cell injury is elevated intraocular pressure (IOP), proinflammatory cytokines also
contribute to the chronic disease. The mechanisms connecting physical strain to
the cytokine response are unclear, however. This proposal is based upon the
novel hypothesis that extracellular ATP links mechanical strain to the enhanced
cytokine response in glaucoma. In particular, the mechanosensitive release of
ATP through pannexin channels on optic nerve astrocytes can autostimulate
adjacent P2X7 receptors, upregulating cytokine expression on a molecular level
and activating cytokine release through both the inflammasome and classic
release pathways. Using in vivo models of elevated IOP and in vitro models of
cell stretch, we will demonstrate the mechanisms linking strain and inflammation
and identify points of intervention. Aim 1 will confirm the involvement of cytokines
IL-1¿ and IL-6 in models of chronic and acute glaucoma. The time course of
cytokine activation will be determined and the relative contribution of
proinflammatory signals in older animals will be assessed. The contribution of
pannexin and P2X7 channels will be explored on a molecular level with knockout
mice, and on a pharmacological level with channel blockers; the ability of
antagonists to reduce inflammasome activation may identify new treatments. In
Aim 2, the mechanisms connecting mechanical strain, ATP and cytokines will be
confirmed in optic nerve head astrocytes while the effects of inflammasome
product IL-1¿ on retinal ganglion cell health will be determined. In summary, this
proposal will demonstrate that purinergic signaling links elevated IOP with the
enhanced inflammatory response in astrocytes and pathology in retinal ganglion
cells. This novel approach will advance our understanding of the disease on a
mechanistic level while identifying possible new targets for intervention.
项目摘要
青光眼是全球失明的主要原因,其特征是
视神经头星形胶质细胞和视网膜的一系列病理变化
有时会导致视力丧失的神经节细胞。而最大的风险因素
细胞损伤是眼内压(IOP),促炎细胞因子也是
有助于慢性疾病。将物理压力连接到的机制
但是,细胞因子反应尚不清楚。该建议基于
细胞外ATP将机械应变与增强的新假设
青光眼中的细胞因子反应。特别是,机械敏感的释放
通过视神经星形胶质细胞上的pannexin通道ATP可以自动刺激
相邻的P2X7受体,分子水平上的细胞因子表达上调
并通过炎症和经典激活细胞因子释放
释放途径。使用升高IOP和体外模型的体内模型
细胞拉伸,我们将演示连接应变和炎症的机制
并确定干预点。 AIM 1将确认细胞因子的参与
慢性和急性青光眼模型中的IL-1和IL-6。时间课程
将确定细胞因子激活,并相对贡献
将评估老年动物的促炎信号。的贡献
Pannexin和P2X7通道将在分子水平上探索,并进行敲除
小鼠,在具有通道阻滞剂的药物水平上;能力
减少炎性体激活的拮抗剂可以鉴定新的治疗方法。在
AIM 2,连接机械应变,ATP和细胞因子的机制将是
在视神经头星形胶质细胞中确认,而炎性体的影响
将确定视网膜神经节细胞健康的产物IL-1。总而言之,这
提案将证明嘌呤能信号链接升高IOP与
残留神经节中星形胶质细胞和病理学的炎症反应增强
细胞。这种新颖的方法将提高我们对疾病的理解
机械水平同时确定可能的新目标进行干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CLAIRE H MITCHELL其他文献
CLAIRE H MITCHELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CLAIRE H MITCHELL', 18)}}的其他基金
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
10368131 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
10595003 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the Health of Retinal Ganglion Cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
8212109 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
7070522 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the Health of Retinal Ganglion Cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
9211326 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
7226619 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the Health of Retinal Ganglion Cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
7781797 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the Health of Retinal Ganglion Cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
8791691 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
7429649 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
Purines and the health of retinal ganglion cells
嘌呤与视网膜神经节细胞的健康
- 批准号:
10250611 - 财政年份:2005
- 资助金额:
$ 29.8万 - 项目类别:
相似国自然基金
粪便mtDNA异质性特征及其在哺乳动物年龄估算中的意义
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
粪便mtDNA异质性特征及其在哺乳动物年龄估算中的意义
- 批准号:32170517
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
EEDA在RPE细胞中的功能及其在年龄相关性视网膜病变中的机制研究
- 批准号:81770946
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
sFlt-1基因靶向敲除诱导鼠新生血管性眼底病及其机制的实验研究
- 批准号:81271016
- 批准年份:2012
- 资助金额:60.0 万元
- 项目类别:面上项目
Robo4基因敲除诱导小鼠年龄相关性视网膜变性及机制研究
- 批准号:81170853
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 29.8万 - 项目类别:
Contribution of Vitamin D Deficiency to Pathological Progression in Models of Cerebral Hypoperfusion
维生素 D 缺乏对脑低灌注模型病理进展的影响
- 批准号:
10725358 - 财政年份:2023
- 资助金额:
$ 29.8万 - 项目类别:
Investigating the origin and functional properties of immune cells in noise-induced hearing loss
研究噪声性听力损失中免疫细胞的起源和功能特性
- 批准号:
10731667 - 财政年份:2023
- 资助金额:
$ 29.8万 - 项目类别: